NICE guidelines (NG87) recommend methylphenidate, lisdexamfetamine, atomoxetine, and guanfacine as first-line pharmacological treatments for ADHD, alongside non-pharmacological approaches such as psychoeducation, CBT, and environmental modifications
Our products are made in cGMP-compliant facilities in the Netherlands, using only the highest quality ingredients
Some laboratory studies suggest that GLP-1 analogues may modulate these neurotransmitter systems, potentially affecting cognitive performance and impulsivity, though these findings remain largely preclinical
Pirnay JP, Djebara S, Steurs G, Griselain J, Cochez C, De Soir S, et al
doi: 10.1186/s40560-022-00611-w [PubMed] 35605086 Heuser K, Olsen KB, Ulvin LB, Gjerstad L, Taubll E